Intellectual Property (Patents)
Diamond v. Chakrabarty, 447 U.S. 303 (1980)
Study notes for Diamond v. Chakrabarty: professor notes, cold call prep, exam angles, and memory aids.
A live, human-made microorganism is patentable as a nonnaturally occurring 'manufacture' or 'composition of matter' under § 101.
In Diamond v. Chakrabarty, the Supreme Court addressed the complex issue of whether genetically engineered living organisms could be patented under U.S. patent law. The case highlights a significant shift in the interpretation of what constitutes 'patentable subject matter' under 35 U.S.C. § 101. Professors often emphasize the implications of this ruling not just for biotechnology, but for the evolution of patent law in a modern context, where advancements in genetics and synthetic biology raise ongoing questions about the boundaries of patentability. The Supreme Court's affirmation suggests that the legal criterion for patentability accommodates innovative scientific deviations from natural phenomena, underlining a conceptual move towards recognizing human ingenuity in creating new and useful inventions.
GEM: Genetically Engineered Microbe.
| Case | Distinction |
|---|---|
| Association for Molecular Pathology v. Myriad Genetics | Myriad held that naturally occurring genes could not be patented, whereas Chakrabarty established that human-made microorganisms can be. |
| Bilski v. Kappos | Bilski focused on abstract ideas not being patentable, whereas Chakrabarty reinforced the patentability of tangible, human-made innovations. |
Allowing patents on genetically engineered organisms encourages innovation in biotechnology, promoting public benefits such as environmental recovery and health advancements.
Granting patents on living organisms raises ethical concerns, including the commodification of life and potential risks of monopolization in essential biological resources.
This case frequently appears in patent law exams, often focusing on the interpretation of § 101 and its implications for patenting living organisms, as well as broader questions related to innovation and technology transfer.